# US 2025/0375384 A1 · Soft dual chambered liquid-gel capsule and method to deliver sublingual and ingestible cannabis compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375384 A1
- Document ID: US20250375384A1
- Status: Published application
- Kind: A1
- Application number: 19/309,116
- Filed: 2025-08-25
- Published: 2025-12-11
- Earliest claimed: 2017-12-01
- Assignees: Healthy Option Consulting Inc.
- Applicants: Healthy Option Consulting Inc.
- Inventors: Andrew Farber
- Web page: https://patentgrep.com/patent/US20250375384A1

## CPC

- A61K 9/4808: {characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084)}
- A61J 1/03: for pills or tablets (containers for pills or tablets with special dispensing means therefor B65D83/04)
- A61J 1/1412: {Containers with closing means, e.g. caps}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE

## Abstract

Provided is a dual chambered liquid-gel capsule 1 having a first chamber 2 containing a sublingual cannabis composition 10 and a second chamber 4 containing an ingestible cannabis composition 12. Also provided is a method of administering the cannabis compositions to a patient in need of the cannabis compositions using the dual chambered liquid-gel capsule.

## Claims

### Claim at position 1

1-7. (canceled)

### Claim 8

A method for supplying a cannabis product to a patient in need of the cannabis product comprising:
providing a soft liquid-gel capsule comprising a first enclosed chamber and a second enclosed chamber, a sublingual cannabis composition contained solely within the first enclosed chamber, and an ingestible cannabis composition contained solely within the second enclosed chamber, a soft-gel wall separating the first enclosed chamber from the second enclosed chamber;
piercing the first enclosed chamber and flowing the sublingual cannabis composition into the patient's mouth and under the patient's tongue;
swallowing the second enclosed chamber; and
allowing the second enclosed chamber to dissolve or break open in the patient's stomach or small intestine to release the oral cannabis composition into the digestive tract.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the liquid-gel capsule is removed from a medicine bottle comprising a lid, the lid comprising an open cylinder formed on or connected to a bottom of the container lid that is sized so that an end of the liquid-gel capsule can be inserted into the open cylinder, a piercing pin is located within the open cylinder, and the open cylinder is defined by a cylinder wall that is longer than the piercing pin so that a patient cannot contact the piercing pin, the method further comprising inserting the liquid-gel capsule into the cylinder so that the piercing pin pierces the first enclosed chamber of the liquid-gel capsule.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the sublingual cannabis composition comprises at least one compound of selected cannabinoids, flavonoids and terpenes.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the ingestible cannabis composition comprises at least one compound of selected cannabinoids, flavonoids and terpenes.

### Claim 12 (depends on 8)

The method according to claim 8, wherein an identifier is present on liquid-gel capsule identifying the presence of THC product, THC/CBD product, CBD product, and/or psychoactive content.

### Claim 13 (depends on 8)

The method according to claim 8, wherein a first identifier is present on liquid-gel capsule identifying a type of the sublingual cannabis composition and a second identifier is present on the liquid-gel capsule identifying a type of the ingestible cannabis composition.

### Claim 14 (depends on 8)

The method according to claim 8, wherein the sublingual cannabis composition is sucked from the first chamber by the patient.

### Claim 15 (depends on 8)

The method according to claim 8, wherein the sublingual cannabis composition disposed within the first chamber is in a liquid state and the ingestible cannabis composition disposed within the second chamber is in a liquid state.

### Claim 16

A method for supplying a cannabis product to a patient in need of the cannabis product comprising:
providing an elongated soft liquid-gel capsule comprising a first enclosed chamber having a first bullet shape and a second enclosed chamber having a second bullet shape, a sublingual cannabis composition contained solely within the first enclosed chamber, and an ingestible cannabis composition contained solely within the second enclosed chamber, a soft-gel wall separating the first enclosed chamber from the second enclosed chamber;
piercing the first enclosed chamber and flowing the sublingual cannabis composition into the patient's mouth and under the patient's tongue;
swallowing the second enclosed chamber; and
allowing the second enclosed chamber to dissolve or break open in the patient's stomach or small intestine to release the oral cannabis composition into the digestive tract.
